OPKO Health, Inc.(OPK) stock price and fundamentals

Medical - Diagnostics & Research · Miami, FL

$1.46-0.11 (-7.01%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About OPKO Health, Inc.

OPKO Health, Inc. operates as a healthcare enterprise with a dual focus on diagnostics and pharmaceuticals. Its operations span the United States, Ireland, Chile, Spain, Israel, Mexico, and other international markets. The company's Diagnostics division encompasses BioReference Laboratories, which delivers a comprehensive suite of laboratory testing services. These services are crucial for disease detection, diagnosis, evaluation, monitoring, and treatment, covering areas such as esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare. BioReference serves a diverse client base, including medical practices, clinics, hospitals, employers, and government entities. Additionally, this segment provides a cutting-edge diagnostic instrument system designed for immediate, point-of-care blood test results, alongside its specialized 4Kscore testing for prostate cancer. Within the Pharmaceutical segment, OPKO offers a range of therapeutic products and a robust development pipeline. Key offerings include Rayaldee, indicated for the management of secondary hyperparathyroidism in adults suffering from stage 3 or 4 chronic kidney disease and vitamin D insufficiency. The pipeline features OPK88004, an investigational orally administered selective androgen receptor modulator; OPK88003, a peptide administered once weekly currently in Phase IIb trials for the treatment of type 2 diabetes and obesity; and hGH-CTP, a once-weekly human growth hormone injection that has successfully completed Phase III clinical trials in collaboration with Pfizer, Inc. A core strategy for this segment involves the development and commercialization of proprietary, extended-release versions of existing therapeutic proteins. Furthermore, OPKO Health supplies specialty active pharmaceutical ingredients (APIs) and is involved in the development, manufacturing, marketing, and sale of pharmaceutical, nutraceutical, veterinary, and ophthalmic products. The company also commercializes food supplements and over-the-counter products, produces and sells items primarily within the generics market, and handles the import, marketing, distribution, and sales of pharmaceutical products across various therapeutic areas, including cardiovascular conditions, vaccines, antibiotics, gastro-intestinal ailments, and hormone-related treatments, among others. Its pharmaceutical operations are further bolstered by platforms situated in Ireland, Chile, Spain, and Mexico. Founded in 1991, OPKO Health, Inc. maintains its corporate headquarters in Miami, Florida.

Miami, FL

2,275 employees

www.opko.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Phillip Frost

View full financials

Stock	Market Cap	Close Price	Price Change	TTM Total Return	5Y CAGR	10Y CAGR	Compare
1OPK	$1.09B	$1.46	-7.01%	-0.64%	-15.39%	-17.50%	N/A
2BCAX	$1.09B	$16.56	-4.22%	-4.12%	N/A	N/A	vs OPK
3IRMD	$1.08B	$84.82	-1.91%	+22.96%	+24.06%	+24.37%	vs OPK
4TRAX	$1.10B	$31.39	-4.85%	N/A	N/A	N/A	vs OPK
5STAA	$1.10B	$22.15	-1.86%	-16.77%	-28.41%	+9.25%	vs OPK
6TNDM	$1.11B	$16.16	-2.18%	+12.24%	-32.93%	-14.43%	vs OPK

Period	Low	Avg	High	# Analysts
Quarter ending Sep 2026	$-0.08	$-0.07	$-0.06	3
Quarter ending Dec 2026	$-0.09	$-0.07	$-0.05	3
Quarter ending Mar 2027	$-0.07	$-0.07	$-0.07	1
Quarter ending Jun 2027	$-0.07	$-0.07	$-0.07	1

Period	Low	Avg	High	# Analysts
FY 2026	$-0.24	$-0.22	$-0.19	4
FY 2027	$-0.29	$-0.27	$-0.22	4

Period	Low	Avg	High	# Analysts
Quarter ending Sep 2026	$135.45M	$136.62M	$138.15M	5
Quarter ending Dec 2026	$143.51M	$145.48M	$148.92M	5
Quarter ending Mar 2027	$136.06M	$138.13M	$141.19M	4
Quarter ending Jun 2027	$143.05M	$145.22M	$148.45M	4

FY 2026	$567.29M	$569.89M	$573.68M	5
FY 2027	$575.93M	$588.95M	$601.89M	5

OPKO Health, Inc.(OPK) stock price and fundamentals

Valuation

Yields

OPK Price Chart

Business at a glance

OPK Key Metrics

Total Return CAGR

OPK Fundamental Charts

Revenue CAGR

OPK Selected Revenue Disclosures

Product / business disclosures (FY 2025)

Geographic disclosures (FY 2025)

OPK Earnings Preview

Similar-Size Sector Stocks

OPK Competitors' Key Metrics

OPK Charts

Valuation Charts

Performance Charts

Dividend Charts

CAGR Charts

Financial Statement Charts

Other Charts

OPK Analyst Ratings

OPK Analyst Estimates

Earnings Per Share (EPS) Estimates

Revenue Estimates